Guided Therapeutics Inc SEC filings GTHP
Guided Therapeutics Inc has 1,000 filings in SEC EDGAR's recent list, going back to Apr 14, 2004. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Mar 10, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 10, 2026 | Mar 2, 2026 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 23, 2024 | Dec 18, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 27, 2024 | Sep 23, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 9, 2023 | Mar 3, 2023 |
| EFFECT | Filing | Jan 25, 2023 | — |
| CORRESP | Letter to the SEC | Jan 23, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 23, 2023 | — |
| S-1 | Registration statement | Jan 13, 2023 | — |
| RW | Filing | Dec 2, 2022 | — |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 15, 2022 | Sep 1, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 29, 2022 | Jul 25, 2022 |
| S-1/A | Amended registration statement | Jul 13, 2022 | — |
| S-1/A | Amended registration statement | Jun 30, 2022 | — |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 10-K | Annual report | Mar 30, 2022 | Dec 31, 2021 |
| S-1/A | Amended registration statement | Feb 17, 2022 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jan 7, 2022 | Jan 6, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| S-1/A | Amended registration statement | Oct 7, 2021 | — |
| S-1 | Registration statement | Sep 29, 2021 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 7, 2021 | Aug 12, 2021 |
| 10-Q | Quarterly report | Aug 18, 2021 | Jun 30, 2021 |
| 10-Q/A | Amended quarterly report | Aug 18, 2021 | Mar 31, 2021 |
| NT 10-Q | Guided therapeutics, inc. | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jul 27, 2021 | Jul 27, 2021 |
| 10-K/A | Amended annual report | Jul 9, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Other events
|
Jul 7, 2021 | Jul 7, 2021 |
| DEF 14A | Proxy statement | Jul 6, 2021 | Jul 2, 2021 |
| PRE 14A | Preliminary proxy statement | Jun 22, 2021 | Jun 22, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Jun 10, 2021 | Jun 10, 2021 |
| 10-Q | Quarterly report | May 21, 2021 | Mar 31, 2021 |
| NT 10-Q | Guided therapeutics, inc. | May 17, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Apr 7, 2021 | Dec 31, 2020 |
| NT 10-K | Guided therapeutics, inc. | Mar 31, 2021 | Dec 31, 2020 |
| 10-Q/A | Amended quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| EFFECT | Filing | Oct 15, 2020 | — |
| CORRESP | Letter to the SEC | Oct 13, 2020 | — |
| S-1/A | Amended registration statement | Oct 8, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2020 | Sep 16, 2020 |
| UPLOAD | Letter from the SEC | Sep 14, 2020 | — |
| S-1 | Registration statement | Sep 10, 2020 | — |
| 10-Q | Quarterly report | Aug 20, 2020 | Jun 30, 2020 |
| NT 10-Q | Guided therapeutics, inc. | Aug 17, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Jul 7, 2020 | Mar 31, 2020 |
| NT 10-Q | Guided therapeutics, inc. | Jun 29, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Other events
|
May 18, 2020 | Mar 31, 2020 |
| 10-K | Annual report | Apr 20, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Mar 31, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Mar 9, 2020 | Sep 30, 2019 |
| 10-Q | Quarterly report | Feb 11, 2020 | Jun 30, 2019 |
| NT 10-Q | Guided therapeutics, inc. | Aug 15, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | Jul 11, 2019 | Mar 31, 2019 |
| NT 10-Q | Guided therapeutics, inc. | May 15, 2019 | Mar 31, 2019 |
| 10-K | Annual report | May 8, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2019 | Apr 3, 2019 |
| NT 10-K | Guided therapeutics, inc. | Apr 1, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 15, 2018 | Nov 14, 2018 |
| 10-Q | Quarterly report | Nov 14, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Oct 25, 2018 | Oct 25, 2018 |
| DEF 14A | Proxy statement | Oct 11, 2018 | Oct 10, 2018 |
| PRE 14A | Preliminary proxy statement | Sep 28, 2018 | Sep 28, 2018 |
| DEF 14A | Proxy statement | Sep 17, 2018 | Sep 17, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Sep 6, 2018 | Aug 31, 2018 |
| PRE 14A | Preliminary proxy statement | Sep 5, 2018 | Sep 5, 2018 |
| 10-Q | Quarterly report | Aug 14, 2018 | Jun 30, 2018 |
| EFFECT | Filing | Jul 10, 2018 | — |
| CORRESP | Letter to the SEC | Jul 9, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2018 | — |
| S-1 | Registration statement | Jun 14, 2018 | — |
| 10-Q | Quarterly report | May 21, 2018 | Mar 31, 2018 |
| NT 10-Q | Guided therapeutics, inc. | May 15, 2018 | Mar 31, 2018 |
| 10-K/A | Amended annual report | Apr 20, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Apr 17, 2018 | Dec 31, 2017 |
| NT 10-K | Guided therapeutics, inc. | Apr 2, 2018 | Dec 31, 2017 |
| 10-Q | Quarterly report | Nov 20, 2017 | Sep 30, 2017 |
| NT 10-Q | Guided therapeutics, inc. | Nov 15, 2017 | Sep 30, 2017 |
| 8-K/A |
Amended current report
Material agreement, New debt, Unregistered share sale
|
Nov 13, 2017 | Nov 9, 2017 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 25, 2017 | Oct 25, 2017 |
| RW | Guided therapeutics, inc. | Sep 25, 2017 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 24, 2017 | Aug 24, 2017 |
| 10-Q | Quarterly report | Aug 18, 2017 | Jun 30, 2017 |
| 8-K/A |
Amended current report
Material agreement
|
Aug 17, 2017 | Aug 8, 2017 |
| NT 10-Q | Filing | Aug 15, 2017 | Jun 30, 2017 |
| 8-K |
Current report
Material agreement
|
Aug 14, 2017 | Aug 8, 2017 |
| S-1/A | Amended registration statement | Jun 26, 2017 | — |
| S-1/A | Amended registration statement | Jun 7, 2017 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 24, 2017 | May 23, 2017 |
| 10-Q | Quarterly report | May 22, 2017 | Mar 31, 2017 |
| NT 10-Q | Guided therapeutics, inc. | May 15, 2017 | Mar 31, 2017 |
| S-1/A | Amended registration statement | Mar 31, 2017 | — |
| 424B3 | Prospectus | Mar 30, 2017 | — |
| 8-K |
Current report
Material agreement
|
Mar 30, 2017 | Mar 30, 2017 |
| 424B3 | Prospectus | Mar 24, 2017 | — |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale
|
Mar 24, 2017 | Jan 22, 2017 |
| 10-K | Annual report | Mar 22, 2017 | Dec 31, 2016 |
| 424B3 | Prospectus | Feb 17, 2017 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 17, 2017 | Feb 16, 2017 |
| 424B3 | Prospectus | Jan 26, 2017 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 26, 2017 | Jan 26, 2017 |
| S-1/A | Amended registration statement | Jan 12, 2017 | — |
| 424B3 | Prospectus | Dec 30, 2016 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 30, 2016 | Dec 30, 2016 |
| S-1/A | Amended registration statement | Dec 9, 2016 | — |
| 424B3 | Prospectus | Dec 8, 2016 | — |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2016 | Dec 8, 2016 |
| 424B3 | Prospectus | Dec 8, 2016 | — |
| 8-K |
Current report
Material agreement
|
Dec 7, 2016 | Dec 7, 2016 |
| 424B3 | Prospectus | Dec 5, 2016 | — |
| 10-Q | Quarterly report | Dec 5, 2016 | Sep 30, 2016 |
| 424B3 | Prospectus | Nov 17, 2016 | — |
| 8-K |
Current report
Officer or director change
|
Nov 17, 2016 | Nov 17, 2016 |
| NT 10-Q | Guided therapeutics, inc. | Nov 15, 2016 | Sep 30, 2016 |
| 424B3 | Prospectus | Nov 4, 2016 | — |
| 8-K |
Current report
Material agreement, Other events
|
Nov 4, 2016 | Nov 4, 2016 |
| 424B3 | Prospectus | Sep 23, 2016 | — |
| 8-K |
Current report
Shareholder vote results
|
Sep 23, 2016 | Sep 23, 2016 |
| 424B3 | Prospectus | Sep 9, 2016 | — |
| 8-K/A |
Amended current report
Material agreement, New debt
|
Sep 9, 2016 | Sep 9, 2016 |
| 424B3 | Prospectus | Sep 8, 2016 | — |
| 8-K |
Current report
Material agreement, New debt
|
Sep 8, 2016 | Sep 8, 2016 |
| DEFA14A | Additional proxy material | Aug 26, 2016 | — |
| DEF 14A | Proxy statement | Aug 25, 2016 | Aug 25, 2016 |
| UPLOAD | Letter from the SEC | Aug 19, 2016 | — |
| PRER14A | Guided therapeutics, inc. | Aug 18, 2016 | — |
| CORRESP | Letter to the SEC | Aug 18, 2016 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 18, 2016 | Aug 18, 2016 |
| 10-Q | Quarterly report | Aug 17, 2016 | Jun 30, 2016 |
| NT 10-Q | Guided therapeutics, inc. | Aug 16, 2016 | Jun 30, 2016 |
| PRE 14A | Preliminary proxy statement | Aug 12, 2016 | Aug 12, 2016 |
| CORRESP | Letter to the SEC | Aug 12, 2016 | — |
| PRE 14A | Preliminary proxy statement | Aug 3, 2016 | Aug 3, 2016 |
| CORRESP | Letter to the SEC | Aug 3, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 27, 2016 | — |
| CORRESP | Letter to the SEC | Jul 19, 2016 | — |
| PRER14A | Preliminary proxy statement | Jul 19, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2016 | — |
| PRE 14A | Preliminary proxy statement | Jul 7, 2016 | Jul 7, 2016 |
| CORRESP | Letter to the SEC | Jul 7, 2016 | — |
| S-1 | Registration statement | Jul 1, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2016 | — |
| CORRESP | Letter to the SEC | Jun 15, 2016 | — |
| PRE 14A | Preliminary proxy statement | Jun 15, 2016 | Jun 15, 2016 |
| 424B3 | Prospectus | Jun 14, 2016 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 14, 2016 | Jun 13, 2016 |
| 424B3 | Prospectus | Jun 8, 2016 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 8, 2016 | Jun 8, 2016 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 19, 2016 | May 19, 2016 |
| 10-Q | Quarterly report | May 19, 2016 | Mar 31, 2016 |
| NT 10-Q | Guided therapeutics, inc. | May 17, 2016 | Mar 31, 2016 |
| 424B3 | Prospectus | May 11, 2016 | — |
| 8-K |
Current report
Officer or director change
|
May 11, 2016 | May 11, 2016 |
| 424B3 | Prospectus | May 4, 2016 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
May 3, 2016 | May 3, 2016 |
| EFFECT | Filing | Apr 7, 2016 | — |
| 424B3 | Prospectus | Apr 7, 2016 | — |
| CORRESP | Letter to the SEC | Apr 5, 2016 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 31, 2016 | Mar 31, 2016 |
| S-1 | Registration statement | Mar 24, 2016 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 15, 2016 | Mar 15, 2016 |
| 10-K | Annual report | Mar 15, 2016 | Dec 31, 2015 |
| 424B3 | Prospectus | Mar 7, 2016 | — |
| 424B3 | Prospectus | Mar 7, 2016 | — |
| 424B3 | Prospectus | Mar 7, 2016 | — |
| 424B3 | Prospectus | Mar 7, 2016 | — |
| 8-K |
Current report
Material agreement
|
Mar 7, 2016 | Mar 7, 2016 |
| 424B3 | Prospectus | Feb 23, 2016 | — |
| 424B3 | Prospectus | Feb 23, 2016 | — |
| 424B3 | Prospectus | Feb 23, 2016 | — |
| 424B3 | Prospectus | Feb 23, 2016 | — |
| 8-K |
Current report
Other events
|
Feb 23, 2016 | Feb 23, 2016 |
| 424B3 | Prospectus | Feb 16, 2016 | — |
| 424B3 | Prospectus | Feb 16, 2016 | — |
| 424B3 | Prospectus | Feb 16, 2016 | — |
| 424B3 | Prospectus | Feb 16, 2016 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change
|
Feb 16, 2016 | Feb 12, 2016 |
| 424B3 | Prospectus | Dec 18, 2015 | — |
| 424B3 | Prospectus | Dec 18, 2015 | — |
| 424B3 | Prospectus | Dec 18, 2015 | — |
| 424B3 | Prospectus | Dec 18, 2015 | — |
| 10-Q/A | Amended quarterly report | Dec 17, 2015 | Sep 30, 2015 |
| 424B3 | Prospectus | Nov 13, 2015 | — |
| 424B3 | Prospectus | Nov 13, 2015 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- GTHP (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Peachtree Corners, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 924515
- Former names
- SPECTRX INC (until Feb 28, 2008)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.